Richard Graydon
Tracked across 1 events · 20 articles · First seen Jul 20, 2026 · Last active Aug 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
GT Biopharma, a United States — Los Angeles-based biopharmaceutical company, terminated its Chief Medical Officer Richard Graydon on July 17, 2026, citing reasons unrelated to his activities at the company. Shortly thereafter, media reports revealed…
Impact: Richard Graydon was the alias used by Ronald L. Fischer while employed at Immix. The false identity triggered the securities investigation.
Jul 20, 2026 · 20 articles
72
GT Biopharma terminated employment Richard GraydonImmix Biopharma executive...
ERGEN INTELLIGENCE
Track Richard Graydon live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard